Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K020395Substantially Equivalent

Amphetamines Enzyme Immunoassay, Catalog #0040 (500 Tests Kit), Catalog #0041 (5000 Tests Kit)

Lin-Zhi International Inc, San Jose CA / Traditional, Substantially Equivalent

K020395 is the FDA 510(k) clearance record for AMPHETAMINES ENZYME IMMUNOASSAY, CATALOG #0040 (500 TESTS KIT), CATALOG #0041 (5000 TESTS KIT), a class II device, cleared for Lin-Zhi International, Inc. on under FDA product code DKZ (Enzyme Immunoassay, Amphetamine). FDA records list 50 510(k) clearances for Lin-Zhi International, Inc., from to . As of , FDA records show no recalls naming K020395.

Clearance record

Decision date
Received
(118 days to decision)
Product code
DKZ Enzyme Immunoassay, Amphetamine
Regulation
21 CFR 862.3100
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Lin-Zhi International, Inc. 2391 Zanker Rd. Suite 340, San Jose CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code DKZ

Trailing 12 months

FDA records hold no clearances under product code DKZ in the trailing twelve months.

FDA records show no clearances under product code DKZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DKZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260